Shindel Alan, Nelson Christian, Brandes Steven
Washington University in Saint Louis-Surgery, Division of Urology, St. Louis, MO, USA.
J Sex Med. 2008 Jan;5(1):199-205. doi: 10.1111/j.1743-6109.2007.00638.x. Epub 2007 Oct 25.
Contemporary U.S. urologist's "real world" practice patterns in treating premature ejaculation (PE) are unknown.
To ascertain contemporary urologist practice patterns in the management of PE.
A randomly generated mailing list of 1,009 practicing urologists was generated from the American Urologic Association (AUA) member directory. A custom-designed survey was mailed to these urologists with a cover letter and a return-address envelope. Responses were compared with the AUA 2004 guidelines for the treatment of PE.
The survey assessed several practice-related factors and asked questions of how the subject would handle various presentations of PE in their practice.
Responses from practicing urologists totaled 207 (21%). Eighty-four percent of the respondents were in private practice and 11% were in academics. Most urologists (73%) saw less than one PE patient per week. On-demand selective serotonin reuptake inhibitor (SSRI) therapy was the most commonly selected first line treatment (26%), with daily dosing a close second (22%). Combination SSRI therapy, the "stop/start" technique, the "squeeze" technique, and topical anesthetics were favored by 13, 18, 18, and 11% of the respondents, respectively. If primary treatment failed, changing dosing of SSRIs, topical anesthetics, and referral to psychiatry were increasingly popular options. Ten percent of urologists would treat PE before erectile dysfunction (ED) in a patient with both conditions, with the remainder of the respondents treating ED first, typically with a phosphodiesterase type 5 inhibitor (78% of total). Fifty-one percent of urologists report that they would inquire about the sexual partner, but only 8, 7, and 4% would evaluate, refer, or treat the partner, respectively.
The majority of our respondents diagnose PE by patient complaint, and treat ED before PE, as per the 2004 PE guidelines. Very few urologists offer referral or treatment to sexual partners of men suffering from PE. Additional randomized studies in the treatment of PE are needed.
当代美国泌尿科医生治疗早泄(PE)的“现实世界”实践模式尚不清楚。
确定当代泌尿科医生在早泄管理方面的实践模式。
从美国泌尿外科学会(AUA)会员名录中随机生成1009名执业泌尿科医生的邮寄名单。将一份定制设计的调查问卷连同一封附信和一个回邮信封邮寄给这些泌尿科医生。将回复与AUA 2004年早泄治疗指南进行比较。
该调查评估了几个与实践相关的因素,并询问了受试者在其实践中如何处理早泄的各种表现。
执业泌尿科医生的回复总数为207份(21%)。84%的受访者从事私人执业,11%从事学术工作。大多数泌尿科医生(73%)每周接诊不到一名早泄患者。按需选择性5-羟色胺再摄取抑制剂(SSRI)疗法是最常被选择的一线治疗方法(26%),每日给药紧随其后(22%)。联合SSRI疗法、“停/启”技术、“挤压”技术和局部麻醉剂分别受到13%、18%、18%和11%受访者的青睐。如果初始治疗失败,改变SSRI剂量、局部麻醉剂以及转诊至精神科是越来越受欢迎的选择。10%的泌尿科医生会在同时患有早泄和勃起功能障碍(ED)的患者中先治疗早泄,其余受访者则先治疗ED,通常使用5型磷酸二酯酶抑制剂(占总数的78%)。51%的泌尿科医生报告说他们会询问性伴侣的情况,但只有8%、7%和4%的医生会分别对伴侣进行评估、转诊或治疗。
根据2004年早泄指南,我们的大多数受访者通过患者主诉诊断早泄,并在治疗早泄之前先治疗ED。很少有泌尿科医生为患有早泄男性的性伴侣提供转诊或治疗。需要进行更多关于早泄治疗的随机研究。